Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sensitivity Profiles of Human Prostate Cancer Cell Lines to an 80 Kinase Inhibitor Panel.

Anticancer research - 1 Feb 2016

Burke Amy J, Ali Husnain, O'Connell Enda, Sullivan Francis J, Glynn Sharon A

Abstract excerpt

BACKGROUND: Taxanes and anti-androgen therapies are routinely used for the treatment of metastatic prostate cancer, however the majority of patients eventually develop resistance. MATERIALS AND METHODS: Eighty kinase inhibitors were screened regarding their ability to inhibit cell viability in CWR22, 22Rv1, PC-3 and DU145 prostate cancer cells using automated toxicity assays. Four kinase inhibitors were selected...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgen Antagonists
Share to Apoptosis
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Prostatic Neoplasms

Share to Protein Kinase Inhibitors

Share to Protein Kinases

Share to Receptors, Androgen

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 26851018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Sensitivity Profiles of Human Prostate Cancer Cell Lines to an 80 Kinase Inhibitor Panel.PMID 26851018Read ↗

Etoposide and topoisomerase II inhibition for aggressive prostate cancer: data from a translational study.Semantic proximity Read ↗

Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study.Semantic proximity Read ↗

Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.Semantic proximity Read ↗

Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide.Semantic proximity Read ↗

Synthetic Lethal Targeting of CDK12-Deficient Prostate Cancer with PARP Inhibitors.Semantic proximity Read ↗

CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.Semantic proximity Read ↗

A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.Semantic proximity Read ↗

A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerSemantic proximity Read ↗

Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.Semantic proximity Read ↗

CUDC‐907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of actionSemantic proximity Read ↗

Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.